CRISPR Therapeutics
CRISPR Therapeutics is pioneering gene editing therapies using CRISPR-Cas9 technology, with approved treatments for sickle cell disease and beta-thalassemia. The company represents the translation of Nobel Prize-winning science into clinical medicine. CRISPR's platform has potential applications across genetic diseases, cancer, and regenerative medicine.